Titan Investment Management LLC Buys New Shares in The Clorox Company $CLX

Titan Investment Management LLC purchased a new stake in The Clorox Company (NYSE:CLX) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 14,038 shares of the company’s stock, valued at approximately $1,415,000.

Several other hedge funds have also recently bought and sold shares of the stock. Norges Bank acquired a new stake in shares of Clorox during the 4th quarter worth approximately $135,735,000. Van ECK Associates Corp lifted its holdings in Clorox by 93.9% in the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after buying an additional 1,312,471 shares during the period. Invesco Ltd. lifted its holdings in Clorox by 22.1% in the fourth quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after buying an additional 884,751 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in Clorox by 6,907.9% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after acquiring an additional 739,005 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new position in Clorox in the second quarter valued at approximately $71,856,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Jefferies Financial Group reduced their price target on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. Evercore reaffirmed an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a research report on Friday, May 1st. TD Cowen upped their target price on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research note on Tuesday, March 31st. Weiss Ratings upgraded Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. Finally, BNP Paribas Exane dropped their price target on Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 12th. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $103.40.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber purchased 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares in the company, valued at $1,544,760. This represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox Trading Up 1.0%

CLX opened at $95.90 on Friday. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03. The company has a 50-day simple moving average of $95.91 and a 200 day simple moving average of $104.88. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The stock has a market capitalization of $11.60 billion, a price-to-earnings ratio of 15.57, a P/E/G ratio of 0.49 and a beta of 0.56.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period last year, the company earned $1.45 EPS. The firm’s revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts predict that The Clorox Company will post 5.61 EPS for the current fiscal year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.